Diasorin's Net Profit Falls By 11.4% In 2013

News: Italy-based medical diagnostics company Diasorin's net profit declined 11.4% year-on-year (y-o-y) to EUR81.8mn (US$112.62mn) in FY13 ended December 31 2013. The decline has been attributed to unfavourable exchange rate fluctuations and the rising expense of supporting the company's molecular division. Diasorin's revenues increased 5.2% y-o-y to EUR229.8mn (US$316.38mn) during the period, while its earnings before interest, taxes, depreciation and amortisation (EBITDA) rose 22.3% y-o-y to EUR57.5mn (US$79.16mn).

This article is tagged to:
Related sectors of this article: Pharmaceuticals & Healthcare
Geography: Italy

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.